The Ipsen Investment Case

Ipsen Specialty-Care sales: FY 2021 Somatuline autogel Oncology Neuroendocrine tumors 1,203 lanreotide Decapeptyl triptorelin Oncology Advanced metastatic prostate 460 cancer Dysport® Neuroscience ☑ Clostridium botulinum Type A Toxin Motor muscular disorders Medical aesthetics 435 CABOMETYX® (cabozantinib) tablets Oncology onivyde® Oncology Metastatic pancreatic cancer 127 (irinotecan liposome injection) RCC: monotherapy and in combination 355 IPSEN Innovation for patient care Other 64 Excludes Consumer Healthcare. RCC: renal cell carcinoma. 7

View entire presentation